CIGB                Neuroprotection 2015
Cuba    USA    Canada    Germany    Netherlands    Czech Republic    Ireland    Brazil    Colombia    Arg    Mex    Ecu  Puerto Rico 
Visitors:
General Info
ORAL PRESENTATIONS   POSTERS    TOPICS
To download the last version of the Scientific Program, please click herePDF



Tuesday, April 7th
Plenary Lectures
17:00 - 17:45 Biomedical Research at the CIGB, Havana Dr.
Gerardo Guillen Nieto
Cuba
17:45 - 18:30 Building Collaborative Links between Ireland and Cuba - A Tale of 2 Populations.
Orla Hardiman
Ireland


Wednesday, April 8th
Oral Presentations
Chairpersons: Dr Myron D. Ginsberg (USA), Dr Diana Garcia del Barco (Cuba)
08:45 - 09:30 Lessons Learned From Preclinical and Clinical Studies of High-Dose Albumin for Neuroprotection In Acute Ischemic Stroke.
Myron D. Ginsberg
USA
09:30 - 10:00 Epidermal Growth Factor and Growth Hormone-Releasing Peptide-6: Combined Therapeutic Approach for Neurodegenerative Diseases
Diana Garcia del Barco
Cuba
10:00 - 10:30 Back to the Future-Using Phenotypic Screening to Identify AD Drug Candidates Pamela Maher USA
10:30 - 10:45 break
10:45 - 11:00 Translation of PSD95 inhibitors from molecular discovery to phase 3 clinical trials David Garman Canada
11:00 - 11:30 Deep Phenotyping and Epidemiology In ALS: The Road to Personalized Medicine? Orla Hardiman Ireland
11:30 - 12:00 New evidences of central and peripheral hyperexcitability in patients with ALS
Joel Gutierrez
Cuba
12:00 - 12:30 Modeling the immunopathogenesis of MS in non-human primates
Bert 't Hart
Netherlands
12:30 - 13:00 Health Systems: Need of Care Policies. An Approach to Cuban Experience
Laura Galeano
Cuba

Thursday, April 9th
Oral Presentations
Chairpersons: Dr Alan Faden (USA), Dr Bert 't Hart (Netherlands)
08:45 - 09:30 Expanding the Neuroprotection Window after TBI: Targeting Delayed Neurotoxic Inflammation
Alan Faden
USA
09:30 – 10:00 Preclinical evaluation of new therapies for MS in the non-human primate
Bert 't Hart
Netherlands
10:00 - 10:30 Bilirubin neurotoxicity and neuroprotection
Libor Vítek
Czech republic
10:30 - 10:45 break
10:45 - 11:15 The Role of Periodontitis in Cognitive Function and Ischaemic Stroke
Wenche S. Borgnakke
USA
11:15 - 11:45 Systemic therapeutic hypothermia in newborns with encephalopathy
Nertor Herrera
Argentina
11:45 – 12:15 Metallothionein: an antioxidant molecule with neuroprotective effects in two models of central nervous system damage.
Araceli Diaz
Mexico
12:15 – 12:45 Characterization of the neuroprotective mechanisms of Dapsone
Camilo Rios
Mexico

Friday, April 10th
Oral Presentations
Chairpersons: Dr Ari Waisman (Germany)
08:45 – 09:30 Mechanisms that leads to the induction and development of multiple sclerosis
Ari Waisman
German
09:30 - 10:00 Neuroprotection of C-Phycocyanin (c-Pc) and Phycocyanobilin (Pcb) in the context of their general pharmacological properties: concepts that may be underlying
Majel Cervantes
Cuba
10:00 - 10:30 Place of Death in Amyotrophic Lateral Sclerosis: Cuban Experience
Tatiana Zaldivar
Cuba
10:30 - 11:00 Bioethical considerations for vulnerable patient populations in international studies. Miriam Bucheli USA

POSTERS
Poster Presentations
Please click the PDF icon on the right to download a Poster.
Nelvys Subirós ASSESSMENT OF DOSE EFFECT AND THERAPEUTIC TIME WINDOW IN PRECLINICAL STUDIES OF EGF AND GHRP-6 CO-ADMINISTRATION FOR STROKE THERAPY PDF
Majel Cervantes-Llanos INTERFERON BETA AND C-PHYCOCYANIN COMBINATION FOR MS TREATMENT PDF
Hector Pérez-Saad MIDDLE CEREBRAL ARTERY OCCLUSION (MCAO) INDUCED BY CALCIUM IN RATS: AN ALTERNATIVE MODEL OF BRAIN ISCHEMIA PDF
Lizet Aldana Velazco SAFETY STUDIES OF EGF + GHRP6 COMBINATION THERAPY FOR THE TREATMENT OF ACUTE PHASE OF CEREBRAL INFARCTION PDF
Mariela Vázquez Castillo THE CIGB INTELLECTUAL PROPERTY STRATEGY FOR PROTECTION OF THE ADVANCED RESULTS IN CONNECTION WITH NEUROPROTECTION PDF
Majel Cervantes-Llanos MOLECULAR CHARACTERIZATION OF NMO AND MS PATIENTS PDF
Dania Bacardi Castillo LIMITATIONS ON THE MOST USED EXPERIMENTAL MODELS FOR DEVELOPING THERAPIES IN MULTIPLE SCLEROSIS AND THE ESTABLISHMENT OF ENDPOINTS PDF


MAIN TOPICS
Neuroprotection Varadero 2015 will highlight the following topics:

► New insights on pathogenic mechanisms
• Epigenetic factors
• Pathways for neuroprotection
• Understanding neuroinflammation
• Neuro-immunology - CNS & PNS.
• Growth factors in CNS diseases


► Translational basic and clinical research
• Targets for neuroprotection
• The holistic view: targeting the neurovascular unit
• Controlling neuroinflammation
• Approaches towards Neuroregeneration and neurorepair
• The holistic approach in research and therapy of neurodegenerative diseases
• Experimental models in neurodegeneration
• Pitfalls in translation: The limitations of animal models
• Biomarkers on the definition and outcome of neurodegenerative diseases
• Stroke - translational research to bridge the gap
• Multiple sclerosis: New therapeutics on the horizon.
• Advances in neurodegenerative disorders: Amyotrophic lateral sclerosis, Alzheimer, Parkinson.

► Future research aims
• Innovative treatment concepts
• Improving the efficiency of the translational timetable
• New designs, outcome measures and ethical issues for clinical trial of neurodegenerative diseases
• Designing research to fulfill regulatory aspects

► Bioethical considerations in Neurological Disease Research

Oral Presentations will be programed in five hour sessions from Tue April 7th to Fri April 10th.

CIGB
Center for Genetic Engineering and Biotechnology, Havana, Cuba
address 31 Ave e/ 158 and 190, Cubanacan, Playa, Havana 10600, Cuba
phone (53-7) 250 4559
(53-7) 271 6022 7421 ext.1140
email biomed@cigb.edu.cu